Table 6

Subgroup analyses: odds ratios (OR) and 95% confidence intervals (95% CI) for main effects with p-value < 0.05.

Age < 39

ER-

ER+

PR-

PR+


Additive

Additive

Additive

Additive

Additive


rs1477196

5.209*

(1.61-16.91)

2.466*

(1.05-5.79)

2.437**

(1.44-4.11)

2.202*

(1.05-4.64)

2.649**

(1.54-4.57)


rs7206790

3.487*

(1.22-9.97)

1.81*

(1.08-3.02)

1.860*

(1.08-3.21)


rs8047395

0.349*

(0.14-0.89)


Stage II

Stage III/IV

Grade I

Grade II

Grade III


Additive

Additive

Additive

Dominance

Additive

Additive


rs1477196

2.368*

(1.21-4.63)

3.640*

(1.63-8.14)

2.766*

(1.07-7.13)

0.345*

(0.15-0.78)

2.405*

(1.22-4.75)

3.067*

(1.49-6.31)


rs7206790

2.319*

(1.12-4.79)

1.921*

(0.99-3.71)


rs8047395

0.361*

(0.16-0.78)


No LN

Yes LN

Her2-

Family hx -

Family hx +


Additive

Additive

Additive

Additive

Additive


rs1477196

2.722*

(1.42-5.22)

2.318*

(1.28-4.18)

2.709**

(1.60-4.58)

3.017**

(1.60-5.67)

2.501*

(1.26-4.93)


rs7206790

1.868*

(1.04-3.35)

2.449*

(1.28-4.69)


*p < 0.05, **p < 0.001

Kaklamani et al. BMC Medical Genetics 2011 12:52   doi:10.1186/1471-2350-12-52

Open Data